Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-catenin

Fig. 3

The expression of Ang-1, SPC, and KGF under the stimulation of LPS alone and combination of liraglutide for 72 h in three MSCs. a Ang-1, SPC, KGF, b Ang-1, c SPC, and d KGF are expressed at protein or mRNA level under the stimulation of 30 μg/mL LPS alone and combination of 10 nM liraglutide at 72 h. Error bars represent mean ± SD from three independent experiments. Compared with the hCMSCs group stimulated by LPS, *P < 0.05, **P < 0.01, and ***P < 0.001; compared with the LPS group corresponding to MSCs, ++P < 0.01 and +++P < 0.001; compared with the hCMSCs group stimulated by LPS and liraglutide, #P < 0.05, ##P < 0.01, and ###P < 0.001; compared with the hBMSCs group stimulated by LPS and with or without liraglutide, $P < 0.05 and $$$P < 0.001. The survival rate of hCMSCs (e), hBMSCs (f), and hAMSCs (g) in the control group, LPS group, and LPS + liraglutide group. Error bars represent mean ± SD from three independent experiments. Compared with the control group corresponding to time points, *P < 0.05, **P < 0.01, and ***P < 0.001; compared with the LPS group corresponding to time points, +P < 0.05, +++P < 0.001

Back to article page